Suchergebnisse - "Korolewicz, James"

PubPharm (8)

1

Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram

enthalten in: Frontiers in immunology | 2024

von Losurdo, A. | Dipasquale, A. | Giordano, L. | +11

2

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

enthalten in: World journal of gastrointestinal oncology | 2023

von Dharmapuri, S. | Özbek, U. | Jethra, H. | +34

3

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

4

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC) : "Real World" Experience

enthalten in: Clinical genitourinary cancer | 2023

von Bakaloudi, D. | Talukder, R. | Lin, G. | +32

5

Ivabradine for inappropriate sinus tachycardia-induced symptomatic Mobitz type I atrio-ventricular block : a case summary

enthalten in: European heart journal. Case reports | 2023

von Korolewicz, J. | Meenakshisundaram, R. | Lim, P.

6

Efficacy and safety of frontline systemic therapy for advanced HCC : A network meta-analysis of landmark phase III trials

enthalten in: JHEP reports : innovation in hepatology | 2023

von Fulgenzi, C. | Scheiner, B. | Korolewicz, J. | +10

7

PETAL protocol : a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma

enthalten in: Future oncology (London, England) | 2023

von Fessas, P. | Scheiner, B. | D'Alessio, A. | +8

8

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma

enthalten in: Journal of hepatocellular carcinoma | 2023

von Manfredi, G. | Celsa, C. | John, C. | +17

1
[1]